Company intelligence / Profile preview

Bioativa

Porto Alegre, Rio Grande do Sul, Brazil

Ownership: Private
Employees: ~25
Development stage: Other

Overview

Bioativa is a Brazilian biotechnology company focused on the development and manufacture of high-tech products for the life sciences and health sectors. Established in 2004 and headquartered in Porto Alegre, the company specializes in recombinant protein production and molecular biology reagents. Their portfolio includes a variety of diagnostic kits for infectious diseases, notably for COVID-19, Dengue, and Zika. In addition to its own product line, Bioativa provides specialized R&D services and contract manufacturing for the biotech industry. The company plays a significant role in the Brazilian diagnostic market by providing locally produced, high-quality biological inputs.

Therapeutic areas: Infectious Diseases
Modalities: Recombinant proteinDiagnostic kit
Industry: Protein Biomarker Diagnostics

Partnerships

Pontifical Catholic University of Rio Grande do Sul (PUCRS)

Beyond the preview

Go deeper on Bioativa.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bioativa.

Explore the full profile